New Autism Spectrum Disorder Clinical Trial: 98% pure CBD for Autism Spectrum Disorder

This trial is testing cannabidiol (CBD) to see if it's an effective treatment for symptoms associated with autism spectrum disorder (ASD), in children and adolescents. They are using a 98% pure CBD oral solution, given at a dose of 9 mg/kg/day. They will be testing up to 15 additional participants who also have a diagnosis of attention deficit/hyperactivity disorder (ADHD). This is a Phase 2 trial recruiting patients with Autism Spectrum Disorder. 00:00:28 How long is the trial? 00:00:38 Who can enroll? 00:01:07 Where is the study located? Discover more information about the trial and apply through Power here: http://bit.ly/3gKq6bK #autismspectrumdisorders #clinicaltrials #autismspectrumdisordersresearch #adhdclinicaltrials